
COLL Valuation
Collegium Pharmaceutical Inc
- Overview
- Forecast
- Valuation
- Earnings
COLL Relative Valuation
COLL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, COLL is overvalued; if below, it's undervalued.
Historical Valuation
Collegium Pharmaceutical Inc (COLL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 4.05 is considered Undervalued compared with the five-year average of 4.66. The fair price of Collegium Pharmaceutical Inc (COLL) is between 32.77 to 45.19 according to relative valuation methord. Compared to the current price of 30.91 USD , Collegium Pharmaceutical Inc is Undervalued By 5.67%.
Relative Value
Fair Zone
32.77-45.19
Current Price:30.91
5.67%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.24
P/B
Median3y
4.44
Median5y
4.10
19.78
FCF Yield
Median3y
21.99
Median5y
18.08
Competitors Valuation Multiple
The average P/S ratio for COLL's competitors is 3.20, providing a benchmark for relative valuation. Collegium Pharmaceutical Inc Corp (COLL) exhibits a P/S ratio of 1.32, which is -58.63% above the industry average. Given its robust revenue growth of 22.66%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

ELVN
Enliven Therapeutics Inc
21.560
USD
-1.42%

TH
Target Hospitality Corp
7.540
USD
0.00%

JBI
Janus International Group Inc
9.070
USD
+5.47%

INOD
Innodata Inc
46.430
USD
-2.74%

KFRC
Kforce Inc
44.410
USD
+3.91%

CSWC
Capital Southwest Corp
23.100
USD
+0.35%

LQDT
Liquidity Services Inc
24.680
USD
+0.65%

PRO
Pros Holdings Inc
15.650
USD
+0.58%

LMB
Limbach Holdings Inc
124.800
USD
+0.78%

OLPX
Olaplex Holdings Inc
1.500
USD
+7.91%
FAQ

Is Collegium Pharmaceutical Inc (COLL) currently overvalued or undervalued?
Collegium Pharmaceutical Inc (COLL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 4.05 is considered Undervalued compared with the five-year average of 4.66. The fair price of Collegium Pharmaceutical Inc (COLL) is between 32.77 to 45.19 according to relative valuation methord. Compared to the current price of 30.91 USD , Collegium Pharmaceutical Inc is Undervalued By 5.67% .

What is Collegium Pharmaceutical Inc (COLL) fair value?

How does COLL's valuation metrics compare to the industry average?

What is the current P/B ratio for Collegium Pharmaceutical Inc (COLL) as of Jul 23 2025?

What is the current FCF Yield for Collegium Pharmaceutical Inc (COLL) as of Jul 23 2025?

What is the current Forward P/E ratio for Collegium Pharmaceutical Inc (COLL) as of Jul 23 2025?
